<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>将其添加为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>生物技术和医疗保健类股票在周三的盘后交易中表现突出，几家小型公司的股价大幅上涨。</p>
<p>IO Biotech, Inc. (IOBT) 股价上涨 19.36%，至 0.25 美元，此前公司宣布将探索一系列旨在最大化股东价值的战略选择。公司指出，考虑的潜在选项包括合并、业务组合、资产出售，甚至清算和解散。此外，IO Biotech 正在评估进一步裁员和其他措施，以在审查这些选择的同时显著降低运营费用。该公告引发了投资者的强烈兴趣，推动股价在盘后交易中上涨。</p>
<p>Cue Biopharma, Inc. (CUE) 在盘后交易中上涨 10.67%，至 0.42 美元。尽管周三没有公司特定的新闻，但这一走势表明投机性交易活动可能推动了股价上涨。</p>
<p>InfuSystem Holdings, Inc. (INFU) 股价在东部时间晚上 7:54 上涨 7.19%，至 9.24 美元。该股在没有任何新公司更新的情况下上涨，延续了医疗服务提供商的强劲趋势。</p>
<p>Cabaletta Bio, Inc. (CABA) 在盘后交易中上涨 7.68%，至 2.52 美元。尽管周三没有新的公告，但投资者可能仍在消化公司 1 月 12 日概述的 2026 年战略优先事项。Cabaletta 强调了支持 rese-cel（resecabtagene autoleucel）开发和上市的计划，同时推进自动化制造创新，以扩大自身在自身免疫疾病中的患者接入。</p>
<p>Iterum Therapeutics plc (ITRM) 在盘后交易中上涨 3.60%，至 0.3284 美元。尽管没有任何新消息，但这只微型生物技术股票在交易结束时仍吸引了适度的买入兴趣。</p>
<p>BioCardia, Inc. (BCDA) 在盘后交易中上涨 3.91%，至 1.33 美元。与其他几只上涨股票类似，该公司周三没有发布任何更新，但其股票在盘后交易中仍吸引了买家。</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

CABA

InfuSystems控股

动态生物技术与基因组 ETF - Invesco

<p>生物科技股票在周三的盘后交易中大幅上涨，IO Biotech 领涨，涨幅达到 19.36%，报 0.25 美元，此前该公司宣布计划探索战略选择以最大化股东价值。其他 notable 的股票包括 Cue Biopharma（上涨 10.67%，报 0.42 美元）、InfuSystem Holdings（上涨 7.19%，报 9.24 美元）和 Cabaletta Bio（上涨 7.68%，报 2.52 美元）。尽管许多股票缺乏具体新闻，但投资者的兴趣依然强烈，推动这些股票在延长交易中上涨</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>将其添加为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Biotech and healthcare names were among the notable movers in Wednesday's after-hours trading session, with several small-cap companies posting sharp gains.</p>
<div class="lb-trans"><p>生物技术和医疗保健类股票在周三的盘后交易中表现突出，几家小型公司的股价大幅上涨。</p>
</div><p>IO Biotech, Inc. (IOBT) surged 19.36% to $0.25 after announcing that it will explore a range of strategic alternatives aimed at maximizing stockholder value. The company noted that potential options under consideration include a merger, business combination, sale of assets, or even liquidation and dissolution. In addition, IO Biotech is evaluating a further reduction-in-force and other measures to significantly cut operating expenses while it reviews these alternatives. The announcement sparked strong investor interest, driving the stock higher in extended trading.</p>
<div class="lb-trans"><p>IO Biotech, Inc. (IOBT) 股价上涨 19.36%，至 0.25 美元，此前公司宣布将探索一系列旨在最大化股东价值的战略选择。公司指出，考虑的潜在选项包括合并、业务组合、资产出售，甚至清算和解散。此外，IO Biotech 正在评估进一步裁员和其他措施，以在审查这些选择的同时显著降低运营费用。该公告引发了投资者的强烈兴趣，推动股价在盘后交易中上涨。</p>
</div><p>Cue Biopharma, Inc. (CUE) advanced 10.67% to $0.42 in after-hours action. The move came despite the absence of company-specific news on Wednesday, suggesting speculative trading activity may have fueled the gain.</p>
<div class="lb-trans"><p>Cue Biopharma, Inc. (CUE) 在盘后交易中上涨 10.67%，至 0.42 美元。尽管周三没有公司特定的新闻，但这一走势表明投机性交易活动可能推动了股价上涨。</p>
</div><p>InfuSystem Holdings, Inc. (INFU) climbed 7.19% to $9.24 as of 7:54 PM EST. The stock rose without any fresh corporate updates, continuing a trend of strength in the medical services provider.</p>
<div class="lb-trans"><p>InfuSystem Holdings, Inc. (INFU) 股价在东部时间晚上 7:54 上涨 7.19%，至 9.24 美元。该股在没有任何新公司更新的情况下上涨，延续了医疗服务提供商的强劲趋势。</p>
</div><p>Cabaletta Bio, Inc. (CABA) added 7.68% to $2.52 in extended trading. While there was no new announcement on Wednesday, investors may still be digesting the company's January 12 update outlining its 2026 strategic priorities. Cabaletta highlighted plans to support the development and launch of rese-cel (resecabtagene autoleucel), while also advancing automated manufacturing innovations to expand patient access in autoimmune diseases.</p>
<div class="lb-trans"><p>Cabaletta Bio, Inc. (CABA) 在盘后交易中上涨 7.68%，至 2.52 美元。尽管周三没有新的公告，但投资者可能仍在消化公司 1 月 12 日概述的 2026 年战略优先事项。Cabaletta 强调了支持 rese-cel（resecabtagene autoleucel）开发和上市的计划，同时推进自动化制造创新，以扩大自身在自身免疫疾病中的患者接入。</p>
</div><p>Iterum Therapeutics plc (ITRM) gained 3.60% to $0.3284 after hours. The move came without any fresh news, but the micro-cap biotech stock saw modest buying interest late in the session.</p>
<div class="lb-trans"><p>Iterum Therapeutics plc (ITRM) 在盘后交易中上涨 3.60%，至 0.3284 美元。尽管没有任何新消息，但这只微型生物技术股票在交易结束时仍吸引了适度的买入兴趣。</p>
</div><p>BioCardia, Inc. (BCDA) rose 3.91% to $1.33 in after-hours trading. Similar to several other gainers, the company did not release any updates on Wednesday, yet shares still attracted buyers in extended activity.</p>
<div class="lb-trans"><p>BioCardia, Inc. (BCDA) 在盘后交易中上涨 3.91%，至 1.33 美元。与其他几只上涨股票类似，该公司周三没有发布任何更新，但其股票在盘后交易中仍吸引了买家。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow

rttnews

Cabaletta Bio

IO Biotech

Cue BioPharma

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

Invesco Nasdaq Biotechnology ETF

生物科技 ETF - VanEck Vectors

基因改革 ETF - ARK

纳斯达克生物科技指数 ETF - iShares Nasdaq

2 倍做多纳斯达克生物技术 ETF - ProShares

标普生物技术 ETF - SPDR

IO BIOTECH INC

生物科技股在盘后交易中大幅上涨：IO Biotech 上涨 19%，Cue Biopharma 和 Cabaletta Bio 也紧随其后